ICPT Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-05-01 | 2022 | Jerome Durso, President & CEO | 714,813 | 0 | 2,547,438 | 634,552 | 23,120 | 4,455,463 |
| 2023-05-01 | 2021 | Jared Freedberg, General Counsel | 423,133 | 0 | 1,633,821 | 208,112 | 21,714 | 3,774,023 |
| 2023-05-01 | 2022 | Jared Freedberg, General Counsel | 477,550 | 0 | 344,329 | 311,884 | 23,120 | 1,311,653 |
| 2023-05-01 | 2022 | Linda Richardson, Chief Commercial Officer | 496,500 | 0 | 344,329 | 324,255 | 16,975 | 1,336,829 |
| 2023-05-01 | 2021 | Michelle Berrey, President of R&D and Chief Medical Officer | 329,545 | 0 | 1,434,983 | 148,970 | 18,321 | 3,118,499 |
| 2023-05-01 | 2022 | Michelle Berrey, President of R&D and Chief Medical Officer | 620,625 | 0 | 344,329 | 472,216 | 22,305 | 1,614,245 |
| 2023-05-01 | 2021 | Andrew Saik, CFO | 251,894 | 102,500 | 1,086,931 | 113,823 | 16,857 | 2,475,854 |
| 2023-05-01 | 2022 | Andrew Saik, CFO | 491,500 | 0 | 344,329 | 373,980 | 23,120 | 1,387,699 |
| 2023-05-01 | 2020 | Jerome Durso, President & CEO | 599,524 | 0 | 2,057,016 | 231,737 | 21,910 | 3,908,963 |
| 2023-05-01 | 2021 | Jerome Durso, President & CEO | 690,750 | 0 | 5,474,865 | 435,994 | 33,945 | 7,870,354 |
| 2022-05-02 | 2021 | Sandip Kapadia, Former CFO | 117,513 | 0 | 1,022,142 | 0 | 59,674 | 1,660,664 |
| 2022-05-02 | 2020 | Sandip Kapadia, Former CFO | 476,863 | 0 | 1,087,836 | 184,039 | 21,910 | 2,298,736 |
| 2022-05-02 | 2019 | Sandip Kapadia, Former CFO | 464,100 | 0 | 1,001,664 | 252,935 | 21,368 | 2,326,640 |
| 2022-05-02 | 2021 | Rocco Venezia, Interim CFO & Chief Accounting Officer | 354,554 | 154,000 | 101,283 | 131,648 | 20,423 | 856,234 |
| 2022-05-02 | 2021 | Jared Freedberg, General Counsel | 423,133 | 0 | 1,633,821 | 208,112 | 21,714 | 3,774,023 |
| 2022-05-02 | 2021 | Michelle Berrey, President of R&D and Chief Medical Officer | 329,545 | 0 | 1,434,983 | 148,970 | 18,321 | 3,118,499 |
| 2022-05-02 | 2021 | Gail Cawkwell, SVP Medical Affairs, Safety & Pharmacovigilance | 478,412 | 750,000 | 748,431 | 216,385 | 31,244 | 2,562,328 |
| 2022-05-02 | 2021 | Jerome Durso, President & CEO | 690,750 | 0 | 5,474,865 | 435,994 | 33,945 | 7,870,354 |
| 2022-05-02 | 2020 | Jerome Durso, President & CEO | 599,524 | 0 | 2,057,016 | 231,737 | 21,910 | 3,908,963 |
| 2022-05-02 | 2019 | Jerome Durso, President & CEO | 573,250 | 0 | 2,089,570 | 359,284 | 21,368 | 4,281,793 |
| 2022-05-02 | 2021 | Andrew Saik, CFO | 251,894 | 102,500 | 1,086,931 | 113,823 | 16,857 | 2,475,854 |
| 2021-04-27 | 2020 | Mark Pruzanski, M.D., President and Chief Executive Officer | 757,850 | 0 | 4,113,504 | 531,995 | 7,660 | 6,427,005 |
| 2021-04-27 | 2020 | Lisa Bright, Former President, International | 480,552 | 0 | 925,704 | 240,955 | 139,106 | 2,239,784 |
| 2021-04-27 | 2019 | Richard Kim, Former President, U.S. Commercial & Strategic Marketing | 442,900 | 202,800 | 890,368 | 265,519 | 76,343 | 2,399,328 |
| 2021-04-27 | 2020 | Richard Kim, Former President, U.S. Commercial & Strategic Marketing | 456,095 | 0 | 1,044,360 | 168,056 | 79,211 | 2,252,850 |
| 2021-04-27 | 2018 | Sandip Kapadia, Chief Financial Officer and Treasurer | 442,000 | 0 | 790,164 | 228,735 | 22,403 | 1,876,846 |
| 2021-04-27 | 2019 | Sandip Kapadia, Chief Financial Officer and Treasurer | 464,100 | 0 | 1,001,664 | 252,935 | 21,368 | 2,326,640 |
| 2021-04-27 | 2020 | Sandip Kapadia, Chief Financial Officer and Treasurer | 476,863 | 0 | 1,087,836 | 184,039 | 21,910 | 2,298,736 |
| 2021-04-27 | 2018 | Jerome Durso, Chief Operating Officer | 540,800 | 0 | 1,554,326 | 292,032 | 22,403 | 3,185,406 |
| 2021-04-27 | 2019 | Jerome Durso, Chief Operating Officer | 573,250 | 0 | 2,089,570 | 359,284 | 21,368 | 4,281,793 |
| 2021-04-27 | 2020 | Jerome Durso, Chief Operating Officer | 599,524 | 0 | 2,057,016 | 231,737 | 21,910 | 3,908,963 |
| 2021-04-27 | 2018 | Mark Pruzanski, M.D., President and Chief Executive Officer | 702,000 | 0 | 1,667,718 | 442,260 | 8,623 | 4,525,960 |
| 2021-04-27 | 2020 | Christian Weyer, M.D., M.A.S., EVP, Research & Development | 486,731 | 0 | 925,704 | 170,804 | 21,910 | 2,058,616 |
| 2021-04-27 | 2018 | Ryan Sullivan, Former General Counsel and Secretary | 376,158 | 0 | 1,239,112 | 229,122 | 173,437 | 3,208,180 |
| 2021-04-27 | 2019 | Ryan Sullivan, Former General Counsel and Secretary | 445,520 | 0 | 1,471,902 | 267,089 | 21,368 | 3,077,592 |
| 2021-04-27 | 2020 | Ryan Sullivan, Former General Counsel and Secretary | 437,107 | 0 | 1,087,836 | 0 | 89,942 | 2,142,973 |
| 2021-04-27 | 2019 | Mark Pruzanski, M.D., President and Chief Executive Officer | 734,292 | 0 | 4,197,742 | 560,265 | 7,368 | 6,615,785 |
| 2020-04-29 | 2017 | Jerome Durso Chief Operating Officer | 441,333 | 0 | 1,738,950 | 260,000 | 26,765 | 3,862,266 |
| 2020-04-29 | 2019 | Ryan Sullivan General Counsel and Secretary | 445,520 | 0 | 1,471,902 | 267,089 | 21,368 | 3,077,592 |
| 2020-04-29 | 2018 | Ryan Sullivan General Counsel and Secretary | 376,158 | 0 | 1,239,112 | 229,122 | 173,437 | 3,208,180 |
| 2020-04-29 | 2019 | Richard Kim President, U.S. Commercial & Strategic Marketing | 442,900 | 202,800 | 890,368 | 265,519 | 76,343 | 2,399,328 |
| 2020-04-29 | 2019 | Dr. Mark Pruzanski President and Chief Executive Officer | 734,292 | 0 | 4,197,742 | 560,265 | 7,368 | 6,615,785 |
| 2020-04-29 | 2018 | Dr. Mark Pruzanski President and Chief Executive Officer | 702,000 | 0 | 1,667,718 | 442,260 | 8,623 | 4,525,960 |
| 2020-04-29 | 2017 | Dr. Mark Pruzanski President and Chief Executive Officer | 675,000 | 0 | 2,486,576 | 401,625 | 7,930 | 6,154,687 |
| 2020-04-29 | 2019 | Sandip Kapadia Chief Financial Officer and Treasurer | 464,100 | 0 | 1,001,664 | 252,935 | 21,368 | 2,326,640 |
| 2020-04-29 | 2018 | Sandip Kapadia Chief Financial Officer and Treasurer | 442,000 | 0 | 790,164 | 228,735 | 22,403 | 1,876,846 |
| 2020-04-29 | 2017 | Sandip Kapadia Chief Financial Officer and Treasurer | 425,000 | 0 | 750,260 | 188,594 | 23,930 | 2,137,016 |
| 2020-04-29 | 2019 | Jerome Durso Chief Operating Officer | 573,250 | 0 | 2,089,570 | 359,284 | 21,368 | 4,281,793 |
| 2020-04-29 | 2018 | Jerome Durso Chief Operating Officer | 540,800 | 0 | 1,554,326 | 292,032 | 22,403 | 3,185,406 |
| 2019-04-30 | 2017 | Sandip Kapadia Chief Financial Officer and Treasurer | 425,000 | 0 | 750,260 | 188,594 | 23,930 | 2,137,016 |
| 2019-04-30 | 2018 | Dr. Mark Pruzanski President and Chief Executive Officer | 702,000 | 0 | 1,667,718 | 442,260 | 8,623 | 4,525,960 |
| 2019-04-30 | 2017 | Dr. Mark Pruzanski President and Chief Executive Officer | 675,000 | 0 | 2,486,576 | 401,625 | 7,930 | 6,154,687 |
| 2019-04-30 | 2016 | Dr. Mark Pruzanski President and Chief Executive Officer | 620,000 | 0 | 2,196,957 | 347,000 | 4,627 | 4,777,033 |
| 2019-04-30 | 2018 | Sandip Kapadia Chief Financial Officer and Treasurer | 442,000 | 0 | 790,164 | 228,735 | 22,403 | 1,876,847 |
| 2019-04-30 | 2016 | Sandip Kapadia Chief Financial Officer and Treasurer | 200,000 | 75,000 | 2,195,400 | 183,000 | 7,057 | 4,219,476 |
| 2019-04-30 | 2018 | Jerome Durso Chief Operating Officer | 540,800 | 0 | 1,554,326 | 292,032 | 22,403 | 3,185,406 |
| 2019-04-30 | 2017 | Jerome Durso Chief Operating Officer | 441,333 | 0 | 1,738,950 | 260,000 | 26,765 | 3,862,266 |
| 2019-04-30 | 2018 | Ryan Sullivan General Counsel and Secretary | 376,158 | 0 | 1,239,112 | 229,122 | 173,437 | 3,208,180 |
| 2019-04-30 | 2018 | Dr. Gail Cawkwell SVP, Medical Affairs, Safety & Pharmacovigilance | 387,317 | 0 | 820,816 | 156,600 | 21,682 | 2,174,698 |
| 2018-04-27 | 2015 | Mark Pruzanski, M.D. President and Chief Executive Officer | 600,000 | 0 | 2,433,516 | 420,000 | 4,627 | 6,425,502 |
| 2018-04-27 | 2017 | Mark Pruzanski, M.D. President and Chief Executive Officer | 675,000 | 0 | 2,486,576 | 401,625 | 7,930 | 6,154,687 |
| 2018-04-27 | 2016 | Mark Pruzanski, M.D. President and Chief Executive Officer | 620,000 | 0 | 2,196,957 | 347,000 | 4,627 | 4,777,033 |
| 2018-04-27 | 2016 | Sandip Kapadia Chief Financial Officer | 200,000 | 75,000 | 2,195,400 | 183,000 | 7,057 | 4,219,476 |
| 2018-04-27 | 2015 | David Shapiro, M.D. Chief Medical Officer | 460,000 | 0 | 829,974 | 184,000 | 29,877 | 2,698,088 |
| 2018-04-27 | 2016 | David Shapiro, M.D. Chief Medical Officer | 475,000 | 0 | 735,462 | 190,000 | 29,877 | 1,968,247 |
| 2018-04-27 | 2017 | David Shapiro, M.D. Chief Medical Officer | 489,300 | 0 | 643,080 | 171,255 | 30,330 | 1,979,854 |
| 2018-04-27 | 2017 | David Ford Chief Human Resources Officer | 246,269 | 0 | 689,400 | 168,625 | 20,010 | 1,912,647 |
| 2018-04-27 | 2017 | Jerome Durso Chief Operating Officer | 441,333 | 0 | 1,738,950 | 260,000 | 26,765 | 3,862,266 |
| 2018-04-27 | 2017 | Sandip Kapadia Chief Financial Officer | 425,000 | 0 | 750,260 | 188,594 | 23,930 | 2,137,016 |
| 2017-05-01 | 2016 | Sandip Kapadia Chief Financial Officer and Treasurer | 200,000 | 75,000 | 2,195,400 | 0 | 7,057 | 4,036,476 |
| 2017-05-01 | 2016 | Rachel McMinn, Ph.D. Chief Strategy and Business Officer | 420,000 | 156,000 | 631,743 | 0 | 16,508 | 1,688,328 |
| 2017-05-01 | 2015 | Rachel McMinn, Ph.D. Chief Strategy and Business Officer | 390,000 | 156,000 | 604,868 | 0 | 16,508 | 2,092,800 |
| 2017-05-01 | 2014 | Rachel McMinn, Ph.D. Chief Strategy and Business Officer | 236,667 | 130,169 | 1,300,263 | 0 | 2,560 | 2,836,560 |
| 2017-05-01 | 2015 | Lisa Bright Chief Commercial and Corporate Affairs Officer | 396,000 | 158,400 | 776,620 | 0 | 140,421 | 2,645,683 |
| 2017-05-01 | 2016 | Lisa Bright Chief Commercial and Corporate Affairs Officer | 367,280 | 135,680 | 780,215 | 0 | 111,854 | 1,932,937 |
| 2017-05-01 | 2016 | Barbara Duncan Former Chief Financial Officer and Treasurer | 322,500 | 327,250 | 584,598 | 0 | 21,168 | 1,682,678 |
| 2017-05-01 | 2015 | Barbara Duncan Former Chief Financial Officer and Treasurer | 415,000 | 166,000 | 604,868 | 0 | 21,168 | 2,132,460 |
| 2017-05-01 | 2014 | Barbara Duncan Former Chief Financial Officer and Treasurer | 372,500 | 148,125 | 400,079 | 0 | 8,527 | 1,284,176 |
| 2017-05-01 | 2016 | Mark Pruzanski, M.D. Chief Executive Officer and President | 620,000 | 420,000 | 2,196,957 | 0 | 4,627 | 4,850,033 |
| 2017-05-01 | 2015 | Mark Pruzanski, M.D. Chief Executive Officer and President | 600,000 | 420,000 | 2,255,185 | 0 | 4,627 | 6,121,565 |
| 2017-05-01 | 2014 | Mark Pruzanski, M.D. Chief Executive Officer and President | 537,500 | 327,250 | 1,249,981 | 0 | 4,444 | 3,228,110 |
| 2017-05-01 | 2016 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 475,000 | 184,000 | 735,462 | 0 | 29,877 | 2,232,247 |
| 2017-05-01 | 2015 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 460,000 | 184,000 | 769,153 | 0 | 29,877 | 2,586,716 |
| 2017-05-01 | 2014 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 409,250 | 165,900 | 400,079 | 0 | 15,052 | 1,345,226 |
| 2016-06-20 | 2014 | Rachel McMinn, Ph.D. Chief Strategy and Business Officer | 236,667 | 130,169 | 1,300,263 | 0 | 2,560 | 2,836,560 |
| 2016-06-20 | 2015 | Daniel Regan Former Chief Commercial Officer | 350,538 | 0 | 0 | 0 | 41,962 | 392,500 |
| 2016-06-20 | 2014 | Daniel Regan Former Chief Commercial Officer | 372,500 | 129,600 | 375,074 | 0 | 21,720 | 1,231,595 |
| 2016-06-20 | 2015 | Rachel McMinn, Ph.D. Chief Strategy and Business Officer | 390,000 | 156,000 | 619,196 | 0 | 16,508 | 2,115,417 |
| 2016-06-20 | 2013 | Barbara Duncan Chief Financial Officer and Treasurer | 331,000 | 225,875 | 95,700 | 0 | 8,013 | 1,378,338 |
| 2016-06-20 | 2014 | Barbara Duncan Chief Financial Officer and Treasurer | 372,500 | 148,125 | 400,079 | 0 | 8,527 | 1,284,176 |
| 2016-06-20 | 2015 | Barbara Duncan Chief Financial Officer and Treasurer | 415,000 | 166,000 | 619,196 | 0 | 21,168 | 2,155,044 |
| 2016-06-20 | 2013 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 377,000 | 249,500 | 95,700 | 0 | 14,874 | 1,454,824 |
| 2016-06-20 | 2014 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 409,250 | 165,900 | 400,079 | 0 | 15,052 | 1,345,226 |
| 2016-06-20 | 2015 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 460,000 | 184,000 | 787,371 | 0 | 29,877 | 2,615,148 |
| 2016-06-20 | 2013 | Mark Pruzanski, M.D. Chief Executive Officer and President | 459,000 | 475,000 | 245,630 | 0 | 4,200 | 3,257,330 |
| 2016-06-20 | 2014 | Mark Pruzanski, M.D. Chief Executive Officer and President | 537,500 | 327,250 | 1,249,981 | 0 | 4,444 | 3,228,110 |
| 2016-06-20 | 2015 | Mark Pruzanski, M.D. Chief Executive Officer and President | 600,000 | 420,000 | 2,308,606 | 0 | 4,627 | 6,200,443 |
| 2016-06-20 | 2013 | Daniel Regan Former Chief Commercial Officer | 277,083 | 167,708 | 0 | 0 | 36,147 | 4,461,165 |
| 2016-06-20 | 2015 | Lisa Bright Chief Commercial and Corporate Affairs Officer | 396,000 | 158,400 | 795,016 | 0 | 140,421 | 2,674,667 |
| 2015-10-29 | 2014 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 409,250 | 165,900 | 400,079 | 0 | 15,052 | 1,345,226 |
| 2015-10-29 | 2013 | Mark Pruzanski, M.D. Chief Executive Officer and President | 459,000 | 475,000 | 245,630 | 0 | 4,200 | 3,257,330 |
| 2015-10-29 | 2014 | Mark Pruzanski, M.D. Chief Executive Officer and President | 537,500 | 327,250 | 1,249,981 | 0 | 4,444 | 3,228,110 |
| 2015-10-29 | 2014 | Rachel McMinn, Ph.D. Chief Strategy and Business Officer | 236,667 | 130,169 | 1,300,263 | 0 | 2,560 | 2,836,560 |
| 2015-10-29 | 2013 | Daniel Regan Chief Commercial Officer | 277,083 | 167,708 | 0 | 0 | 36,147 | 4,461,165 |
| 2015-10-29 | 2014 | Daniel Regan Chief Commercial Officer | 372,500 | 129,600 | 375,074 | 0 | 21,720 | 1,231,595 |
| 2015-10-29 | 2012 | Barbara Duncan Chief Financial Officer and Treasurer | 323,000 | 152,000 | 446,533 | 0 | 8,816 | 1,177,017 |
| 2015-10-29 | 2013 | Barbara Duncan Chief Financial Officer and Treasurer | 331,000 | 225,875 | 95,700 | 0 | 8,013 | 1,378,338 |
| 2015-10-29 | 2014 | Barbara Duncan Chief Financial Officer and Treasurer | 372,500 | 148,125 | 400,079 | 0 | 8,527 | 1,284,176 |
| 2015-10-29 | 2012 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 375,000 | 140,000 | 558,161 | 0 | 13,621 | 1,395,108 |
| 2015-10-29 | 2013 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 377,000 | 249,500 | 95,700 | 0 | 14,874 | 1,414,824 |
| 2015-10-29 | 2012 | Mark Pruzanski, M.D. Chief Executive Officer and President | 377,000 | 332,063 | 1,674,506 | 0 | 2,373 | 3,310,938 |
| 2014-06-23 | 2013 | Barbara Duncan Chief Financial Officer and Treasurer | 331,000 | 225,875 | 95,700 | 0 | 8,013 | 1,378,338 |
| 2014-06-23 | 2012 | Barbara Duncan Chief Financial Officer and Treasurer | 323,000 | 152,000 | 446,533 | 0 | 8,816 | 1,177,017 |
| 2014-06-23 | 2013 | Mark Pruzanski, M.D. Chief Executive Officer and President | 459,000 | 475,000 | 245,630 | 0 | 4,200 | 3,257,330 |
| 2014-06-23 | 2012 | Mark Pruzanski, M.D. Chief Executive Officer and President | 377,000 | 332,063 | 1,674,506 | 0 | 2,373 | 3,310,938 |
| 2014-06-23 | 2013 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 377,000 | 249,500 | 95,700 | 0 | 14,874 | 1,414,824 |
| 2014-06-23 | 2012 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 375,000 | 140,000 | 558,161 | 0 | 13,621 | 1,395,108 |
| 2013-04-12 | 2011 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 363,998 | 0 | 0 | 83,720 | 12,000 | 563,951 |
| 2013-04-12 | 2011 | Mark Pruzanski, M.D. Chief Executive Officer and President | 364,000 | 0 | 0 | 147,420 | 0 | 830,745 |
| 2013-04-12 | 2012 | Mark Pruzanski, M.D. Chief Executive Officer and President | 377,000 | 120,000 | 1,674,506 | 212,063 | 2,373 | 3,310,938 |
| 2013-04-12 | 2011 | Barbara Duncan Chief Financial Officer and Treasurer | 312,000 | 0 | 0 | 71,760 | 6,412 | 483,560 |
| 2013-04-12 | 2012 | Barbara Duncan Chief Financial Officer and Treasurer | 323,000 | 46,016 | 446,533 | 105,984 | 8,816 | 1,177,017 |
| 2013-04-12 | 2012 | David Shapiro, M.D. Chief Medical Officer and Executive Vice President, Development | 375,000 | 16,953 | 558,161 | 123,047 | 13,621 | 1,395,108 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
